Rapid Medical Obtains FDA Clearance for the World's Smallest and Only Adjustable Thrombectomy Device
On July 26, 2022, Rapid Medical, a leading developer of advanced neurovascular devices, received Food and Drug Administration (FDA) 510(k) clearance for TIGERTRIEVER™13 for large vessel occlusions.
The TIGERTRIEVER 13 is the world's smallest revascularization device, designed to remove thrombus from delicate brain blood vessels during an ischemic stroke. It is the only device that adapts to the vasculature and clot, which is a less traumatic approach than other devices.
The TIGERTRIEVER portfolio's unique adjustability arises from the ...
